Cumulus Advances Alzheimer’s Research with NeuLogiq Platform
BELFAST, Northern Ireland, June 30, 2026 Cumulus Neuroscience has announced the publication of new findings in Frontiers in Digital...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
BELFAST, Northern Ireland, June 30, 2026 Cumulus Neuroscience has announced the publication of new findings in Frontiers in Digital...
LOS ANGELES, Calif., June 30, 2026 STARMED America has achieved a historic milestone in thyroid disease treatment after receiving...
SAN FRANCISCO, June 10, 2026 Matter Bio has announced that the U.S. Food and Drug Administration (FDA) has cleared...
TORONTO, June 9, 2026 SpinaFX Medical has achieved a major regulatory milestone after receiving U.S. Food and Drug Administration...
PARIS, France, May 20, 2026 Sensome continues to expand the clinical and commercial development of its smart guidewire platform...
WESTMINSTER, Colo. – May 4, 2026 TriSalus Life Sciences has announced the initiation of patient enrollment for its PREDICTT...
LONDON, April 23, 2026 In a significant advancement for vascular access treatment, FLEX Vascular has announced 12-month real-world outcomes...
Alameda, California | April 13, 2026 Penumbra, Inc. has announced compelling 90-day results from the STORM-PE randomized controlled trial,...
AMSTERDAM, the Netherlands, March 3, 2026 The SHERPA research consortium, coordinated by Royal Philips, has initiated seven clinical studies...
